Patent details

EP3125885 Title: COMBINATION OF EGFR INHIBITOR AND MEK INHIBITOR FOR USE IN THE TREATMENT OF NRAS MUTATED CANCER

Basic Information

Publication number:
EP3125885
PCT Application Number:
GB2015051042
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157158056
PCT Publication Number:
WO2015150826
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF EGFR INHIBITOR AND MEK INHIBITOR FOR USE IN THE TREATMENT OF NRAS MUTATED CANCER
French Title of Invention:
COMBINAISON D'UN INHIBITEUR DE EGFR ET UN INHIBITEUR DE MEK POUR L'UTILISATION DANS LE TRAITEMENT D'UN CANCER MUTÉ SUR NRAS
German Title of Invention:
KOMBINATION VON EGFR-HEMMER UND MEK-HEMMER ZUR VERWENDUNG BEI DER BEHANDLUNG VON NRAS-MUTIERTEM KREBS
SPC Number:

Dates

Filing date:
02/04/2015
Grant date:
30/06/2021
EP Publication Date:
08/02/2017
PCT Publication Date:
08/10/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/06/2021
EP B1 Publication Date:
30/06/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/04/2022
Expiration date:
02/04/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/06/2021
 
 

Name:
Astrazeneca AB
Address:
Forskargatan 18, 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:
EBERLEIN, Catherine Anne
Address:
United Kingdom (GB)

2

Name:
CROSS, Darren Anthony Edward
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201461975088 P
Priority Date:
04/04/2014
Priority Country:
United States (US)

2

Priority Number:
201462013573 P
Priority Date:
18/06/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4184; A61K 31/506; A61P 35/00; A61K 31/5377;

Publication

European Patent Bulletin

Issue number:
202126
Publication date:
30/06/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages